Oultram, J.M.J.; Pegler, J.L.; Bowser, T.A.; Ney, L.J.; Eamens, A.L.; Grof, C.P.L.
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines 2021, 9, 234.
https://doi.org/10.3390/biomedicines9030234
AMA Style
Oultram JMJ, Pegler JL, Bowser TA, Ney LJ, Eamens AL, Grof CPL.
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines. 2021; 9(3):234.
https://doi.org/10.3390/biomedicines9030234
Chicago/Turabian Style
Oultram, Jackson M. J., Joseph L. Pegler, Timothy A. Bowser, Luke J. Ney, Andrew L. Eamens, and Christopher P. L. Grof.
2021. "Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC" Biomedicines 9, no. 3: 234.
https://doi.org/10.3390/biomedicines9030234
APA Style
Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L.
(2021). Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines, 9(3), 234.
https://doi.org/10.3390/biomedicines9030234